What's new

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 64, Status: Authorised

Apr 16, 2025 - 10:49
 0
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 64, Status: Authorised
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 64, Status: Authorised
Read More

Tags:

Previous Article

Trade body HEVRA opens arms to bodyshops

Next Article

Minutes of the CVMP meeting 11-13 March 2025

Related Posts

Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d] pyrimidin-6-yl)phenyl)methacrylamide hydrochloride Treatment of biliary tract cancer, 10/11/2022 Positive

Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-met...

Feb 24, 2025  0

Development of the Clinical Trials Information System

Development of the Clinical Trials Information System

Feb 20, 2025  0